Black Diamond Therapeutics, Inc., a clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The company's lead product candidate is silevertinib, a brain...
Leadership
Mark A. Velleca M.D., Ph.D.
CEO, President & Chairman
Brent Hatzis-Schoch Esq., J.D.
COO & General Counsel
Sergey Yurasov M.D., Ph.D.
Chief Medical Officer
Elizabeth Buck Ph.D.Founder
Co-Founder & Chief Scientific Officer
Erika Jones
Principal Financial Officer, Principal Accounting Officer, SVP of Finance & Corporate Controller
